Guohua Pan

Author PubWeight™ 40.75^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.	N Engl J Med	2011	28.99
2	Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.	Genes Dev	2011	2.97
3	Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study.	Schizophr Res	2007	1.68
4	Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.	J Am Heart Assoc	2013	1.26
5	Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge.	ACS Chem Biol	2014	0.97
6	Gamma-synuclein is an adipocyte-neuron gene coordinately expressed with leptin and increased in human obesity.	J Nutr	2008	0.97
7	The discovery of Polo-like kinase 4 inhibitors: identification of (1R,2S).2-(3-((E).4-(((cis).2,6-dimethylmorpholino)methyl)styryl). 1H.indazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one (CFI-400945) as a potent, orally active antitumor agent.	J Med Chem	2015	0.87
8	Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions.	Ann N Y Acad Sci	2013	0.86
9	Albumin stimulates the accumulation of extracellular matrix in renal tubular epithelial cells.	Am J Nephrol	2003	0.83
10	The discovery of PLK4 inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as novel antiproliferative agents.	J Med Chem	2013	0.82
11	Targeting HER2+ breast cancer cells: lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticles.	J Control Release	2013	0.79
12	Nanocage structure derived from sulfonated β-cyclodextrin intercalated layered double hydroxides and selective adsorption for phenol compounds.	Inorg Chem	2014	0.78
13	The discovery of Polo-like kinase 4 inhibitors: design and optimization of spiro[cyclopropane-1,3'[3H]indol]-2'(1'H).ones as orally bioavailable antitumor agents.	J Med Chem	2014	0.78
14	Bias and variance evaluation of QT interval correction methods.	J Biopharm Stat	2008	0.77
15	Point-of-Care Device for Warfarin Monitoring Used in the J-ROCKET AF Study.	Circ J	2016	0.75